Plasmacytoma and support therapy with calcitonin
Adam, Z.
Vnitrni Lekarstvi 37(11-12): 898-900
1991
ISSN/ISBN: 0042-773X PMID: 1796564 Document Number: 373718
The author describes the excellent effect of two-years therapy of a female patient suffering from multiple myeloma, using the calcitonin preparation Miacalcic Sandoz. During the two and a half year follow up of the patient only a small progression of the bone affection occurred. The patient who on account of pain was treated with opiates was unable to walk unaided, now walks does not take analgesics.
Document emailed within 1 workday
Related Documents
Guida, M.; Casamassima, A.; Abbate, I.; Paradiso, A.; Zito, A.; Marzullo, F.; Lorusso, V.; Timurian, A.; Cramarossa, A.; De Lena, M. 1994: Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different nosological entities? Tumori 80(5): 370-377Ziegler, R.; Raue, F. 1984: Variations of plasma calcitonin levels measured by radioimmunoassay systems for human calcitonin Biomedicine and PharmacoTherapy 38(5): 245-251
Yiin, K.T.; Chiang, C.D.; Chen, C.F.; Wang, S.J.; Lin, W.H.; Guu, C.J.; Lee, H.K.; Jih, K.S.; Lin, T.M.; Huang, W.L. 1987: The serum levels of human calcitonin (hCT) and salmon calcitonin (sCT) in lung cancer patients Zhonghua Yi Xue Za Zhi 40(6): 517-522
Dopplet, S.H.; Talmage, R.V. 1976: Calcitonin and the bone fluid compartment: effect of calcitonin and/or parathyroid hormone on plasma radiocalcium changes Clinical Orthopaedics and Related Research 118: 242-250
Suva, L.J.; Flannery, M.S.; Caulfield, M.P.; Findlay, D.M.; Jüppner, H.; Goldring, S.R.; Rosenblatt, M.; Chorev, M. 1997: Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor Journal of Pharmacology and Experimental Therapeutics 283(2): 876-884
Lubet, R.A.; Carlson, D.E. 1978: Therapy of the murine plasmacytoma MOPC 104E: role of the immune response Journal of the National Cancer Institute 61(3): 897-903
Saller, B.; Goerges, R.; Reinhardt, W.; Haupt, K.; Janssen, O.E.; Mann, K. 2002: Sensitive Calcitonin Measurement by Two-site Immunometric Assays: Implications for Calcitonin Screening in Nodular Thyroid Disease Clinical Laboratory 48(3-4): 191-200
Avioli, L.V. 1990: Calcitonin therapy in osteoporotic syndromes Journal of the American Medical Women's Association 45(3): 103-107
Galán Galán, F.; Garrido Peralta, M. 1982: Calcitonin as a tumor marker. II. Calcitonin in non-thyroid tumors Revista Clinica Espanola 165(2): 73-76
Il'in, N.V.; Leenman, E.E.; Vinogradova, I.N.; Gracheva, A.V.; Tokaeva, A.V. 2012: Value of distant radiotherapy for patients with multiple myeloma and plasmacytoma in the era of modern pharmacologic therapy Voprosy Onkologii 58(6): 821-825
Zurborn, K.H.; Sondermann, I.; Gross, W.L. 1985: Decrease of paraprotein secretion despite progressive tumor cell proliferation by cytostatic drug therapy of plasmacytoma Der Internist 26(9): 584-586
Vigo, P.; Girardello, R.; Soldati, L.; Favini, P.; Ortolani, S.; Polli, E.E. 1979: Therapy of senile osteoporosis with porcine extraction calcitonin in paraphysiological doses Recenti Progressi in Medicina 66(6): 607-626
Wenz, W.; Basler, L. 1985: Significance of x-ray diagnosis in the control of calcitonin therapy of Paget's disease: case report Der Radiologe 25(12): 594-596
Akhundov, S.N.; Toritsina, L.K.; Karina, I.M. 1985: Serum parathyroid hormone and calcitonin levels in bronchial asthma in relation to glucocorticoid therapy Klinicheskaia Meditsina 63(6): 71-74
Rizzato, G.; Tosi, G.; Schiraldi, G.; Montemurro, L.; Zanni, D.; Sisti, S. 1988: Bone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis Sarcoidosis 5(2): 99-103
Lamari, Y.; Tahri, E.H.; Collignon, H.; Garel, J.M. 1994: Steroid hormones and retinoic acid interact in the regulation of calcitonin and calcitonin gene-related peptide secretion and messenger ribonucleic acid levels in CA-77 C cells Cellular and Molecular Biology 40(4): 541-550
Ishida, M.; Yamada, M. 1991: Calcitonin for therapy of renal osteodystrophy due to long-term hemodialysis in patients with chronic kidney failure Nihon Rinsho. Japanese Journal of Clinical Medicine 49 Suppl: 725-731
Bendkowski, W.; Hadas, E.; Swietochowska, E.; Wielkoszyński, T.; Ostrowska, Z.; Szapska, B. 2002: Influence of dithranol therapy on clinical status and serum calcitonin concentrations in patients with common psoriasis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(78): 481-483
Constantin, I.; Serban, F.; Cringu, A.; Constantin, L.V. 1988: Adjuvant therapy for support of an endodontic therapy. 1: Experimental bases Stomatologie der DDR 38(8): 510-513
Szücs, J.; Steczek, K. 1978: Calcitonin sensitivity testing in patients with kidney diseases. Changes in serum calcium, phosphorus and plasma cyclic adenosine monophosphate levels under the effect of calcitonin in healthy subjects and uremic patients under chronic hemodialysis Orvosi Hetilap 119(20): 1220-1224